A first proof of concept study of CB-03-01 for the treatment of androgenetic alopecia
Latest Information Update: 13 Dec 2022
At a glance
- Drugs Clascoterone (Primary)
- Indications Alopecia
- Focus Proof of concept; Therapeutic Use
- Sponsors Cosmo Pharmaceuticals